A detailed history of Black Rock Inc. transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,550,207 shares of CGEM stock, worth $47.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,550,207
Previous 2,428,993 46.16%
Holding current value
$47.8 Million
Previous $41.4 Million 49.59%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$15.63 - $29.35 $17.5 Million - $32.9 Million
1,121,214 Added 46.16%
3,550,207 $61.9 Million
Q1 2024

May 10, 2024

SELL
$10.17 - $19.02 $338,467 - $633,004
-33,281 Reduced 1.35%
2,428,993 $41.4 Million
Q4 2023

Feb 13, 2024

BUY
$7.89 - $10.23 $1.78 Million - $2.31 Million
225,989 Added 10.11%
2,462,274 $25.1 Million
Q3 2023

Nov 13, 2023

BUY
$9.05 - $11.72 $1.2 Million - $1.55 Million
132,216 Added 6.28%
2,236,285 $20.2 Million
Q2 2023

Aug 11, 2023

SELL
$8.8 - $13.4 $1.33 Million - $2.03 Million
-151,528 Reduced 6.72%
2,104,069 $22.6 Million
Q1 2023

May 12, 2023

SELL
$10.2 - $11.91 $2.56 Million - $2.98 Million
-250,618 Reduced 10.0%
2,255,597 $23.1 Million
Q4 2022

Feb 13, 2023

BUY
$9.72 - $13.62 $1.28 Million - $1.79 Million
131,390 Added 5.53%
2,506,215 $26.4 Million
Q3 2022

Nov 14, 2022

BUY
$11.82 - $15.42 $1.69 Million - $2.21 Million
143,098 Added 6.41%
2,374,825 $30.4 Million
Q2 2022

Aug 12, 2022

BUY
$7.31 - $13.55 $2.96 Million - $5.5 Million
405,558 Added 22.21%
2,231,727 $28.6 Million
Q1 2022

May 12, 2022

SELL
$10.47 - $16.75 $135,513 - $216,795
-12,943 Reduced 0.7%
1,826,169 $19.1 Million
Q4 2021

Feb 10, 2022

BUY
$15.36 - $25.0 $3.22 Million - $5.24 Million
209,518 Added 12.86%
1,839,112 $28.4 Million
Q3 2021

Nov 09, 2021

BUY
$22.56 - $29.68 $15.5 Million - $20.4 Million
687,316 Added 72.94%
1,629,594 $36.8 Million
Q2 2021

Aug 11, 2021

BUY
$24.96 - $41.25 $23.5 Million - $38.9 Million
942,278 New
942,278 $24.3 Million

Others Institutions Holding CGEM

About Cullinan Oncology, Inc.


  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $613M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.